Related Experiment Video
Updated: Feb 27, 2026

13:47
Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
26.5K
ReMeDy: A Flexible Statistical Framework For Region-based Detection of DNA Methylation Dysregulation
Suvo Chatterjee1, Siddhant Meshram1, Ganesan Arunkumar2
1Department of Epidemiology and Biostatistics, Indiana University, Bloomington, IN, USA.
Biorxiv : the Preprint Server for Biology
|February 26, 2026
Summary
ReMeDy, a new statistical framework, identifies methylation changes in DNA by analyzing mean and variability within genomic regions. This approach enhances the discovery of disease-associated epigenetic markers compared to traditional methods.
Area of Science:
- Epigenetics
- Genomics
- Statistical Bioinformatics
Background:
- Region-based epigenome-wide association studies (eGWAS) offer advantages over probe-wise analyses for DNA methylation data.
- Current region-based methods primarily focus on mean methylation changes, neglecting alterations in methylation variability.
Purpose of the Study:
- To develop a statistical framework that jointly models mean and variance changes in DNA methylation within regions.
- To identify differentially methylated regions (DMRs), variably methylated regions (VMRs), and regions with joint differential and variable methylation.
Main Methods:
- Proposed ReMeDy, a flexible framework using a hierarchical likelihood approach within a generalized linear model.
- Operates directly on biologically defined co-methylated regions to capture spatial correlation.
- Avoids heuristic tuning parameters, reducing subjectivity.
Main Results:
- ReMeDy maintains false discovery and type-I error rates at nominal levels in simulations.
- Consistently achieves higher statistical power across various realistic scenarios compared to existing models.
- Identifies biologically meaningful regions and pathways implicated in complex human diseases from population-level data.
Conclusions:
- ReMeDy provides a robust method for analyzing DNA methylation variability and mean changes in a region-based manner.
- Offers improved biological interpretability and statistical power for eGWAS.
- Identifies novel disease-associated epigenetic markers missed by conventional mean-based analyses.

